TYMLOS is an anabolic agent that helps build new bone1
TYMLOS reduces the risk of vertebraland nonvertebral fractures and increases BMD.1,2
See safety data for TYMLOS.
Get access to everything you need to knowabout prescribing TYMLOS.
Use this form to enroll patients in the TYMLOSsupport program.
BMD=bone mineral density.
References: 1. TYMLOS [prescribing information]. Boston, MA: Radius Health, Inc. 2. Miller PD, Hattersley G, Riis BJ, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):22-33 [published correction appears in JAMA. 2017;317(4):442]. 3. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res. 2007;22(3):425-433.